ACT
Enact Holdings, Inc.
ACT's fundamentals are mixed, but it looks expensive: trading at 9.5x earnings, above its usual 7.6x. Analysts expect earnings growth.
BLK
BlackRock, Inc.
BLK's fundamentals are mixed, but it looks expensive: trading at 28x earnings, above its usual 22x.
ACT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
ACT's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ACT.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
ACT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $28.70 | -37% |
| Fair | 7.6x | $36.40 | -21% |
| Expensive | 9.1x | $43.53 | -5% |
| Forward | 9.2x | $45.83 | — |
| Current | 9.5x | $45.83 | — |
Historical ranges are pointers, not guarantees.
ACT has the edge over BLK in the historical PE scenario, which offers more potential upside but is not a forecast.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
ACT Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect ACT's earnings to grow and its profitability to improve, with its revenue holding steady.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
ACT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.96 | +3.1% |
| Q3 2026 | $4.81 | +11% |
| Q2 2026 | $4.76 | +8.4% |
| Q1 2026 | $4.62 | +4.1% |
| Q4 2025 | $4.52 | +3.4% |
| Q3 2025 | $4.34 | +1.2% |
| Q2 2025 | $4.39 | +5.5% |
| Q1 2025 | $4.44 | +9.9% |
| Q4 2024 | $4.37 | +6.3% |
ACT has the edge over BLK on earnings, with more consistent year-over-year improvement.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK earned $43.87 per share over the past year, up 11% from the year before.
ACT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $312.9M | +0.4% |
| Q2 2026 | $317.3M | +4.1% |
| Q1 2026 | $312.1M | +1.7% |
| Q4 2025 | $312.7M | +3.6% |
| Q3 2025 | $311.5M | +0.6% |
| Q2 2025 | $304.9M | +2% |
| Q1 2025 | $306.8M | +5.2% |
| Q4 2024 | $301.8M | +1.9% |
ACT's revenue has grown year over year for 16 quarters in a row: $313M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 65% | -2.5 points |
| Q2 2026 | 69% | -1 points |
| Q1 2026 | 68% | -0.5 points |
| Q4 2025 | 71% | +2.5 points |
| Q3 2025 | 67% | -6.8 points |
| Q2 2025 | 70% | -8.2 points |
| Q1 2025 | 69% | -1.7 points |
| Q4 2024 | 69% | +1.4 points |
ACT has the edge over BLK on profitability, with a higher operating margin.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over ACT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
ACT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $183.9M | -4.2% |
| Q2 2026 | $118.5M | -0.8% |
| Q1 2026 | $224M | -1.2% |
| Q4 2025 | $186.3M | +12% |
| Q3 2025 | $192M | +2.1% |
| Q2 2025 | $119.5M | -17% |
| Q1 2025 | $226.7M | +21% |
| Q4 2024 | $166.1M | -13% |
ACT's free cash flow was $713M over the past year, up 1.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like ACT.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the edge over ACT on cash flow, with more consistent year-over-year improvement.
ACT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -2M shares |
| 1 year | -6.8% | -10M shares |
| 3 years | -14% | -22.9M shares |
| 5 years | -15% | -24.6M shares |
| Available history | -15% | -24.5M shares |
ACT has the edge over BLK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $117.9M |
| Q2 2026 | $93.3M |
| Q1 2026 | $93.2M |
| Q4 2025 | $127M |
| Q3 2025 | $105.5M |
| Q2 2025 | $84.6M |
| Q1 2025 | $65.3M |
| Q4 2024 | $74.6M |
ACT spent $431M buying back its own shares over the past year, up 31% from the year before.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has 165M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
ACT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 0.5x | Very low |
| Q4 2020 | 0.6x | Very low |
| Q3 2020 | 0.3x | Very low |
| Q2 2020 | -0.6x | Net Cash |
| Q4 2019 | -0.4x | Net Cash |
ACT's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like ACT.
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
ACT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.5 | Neutral |
| Stochastic | 47.2 | Neutral |
ACT's weekly RSI is 49 (neutral) and its Stochastic is 47 (neutral).
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
ACT PE vs Financial Services Sector
| Metric | ACT | Sector median | Relative |
|---|---|---|---|
| PE | 9.5x | 13x | 27% below |
| PE % | 90 | 65 | 25 pts above |
ACT has the edge over BLK on valuation relative to its sector.
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
ACT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.5 | 1.4% below |
| 20 week MA | $47.3 | 3.2% below |
| 50 week MA | $43.8 | 4.6% above |
| 100 week MA | $39.7 | 15% above |
| 200 week MA | $34.3 | 33% above |
ACT has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 33% above its 200-week average.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK has the edge over ACT on trend strength, trading above more of its moving averages.
ACT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.0 | $20.0 | +0.1% |
| 2022 | $20.0 | $24.2 | +21% |
| 2023 | $24.2 | $28.9 | +19% |
| 2024 | $28.9 | $32.4 | +12% |
| 2025 | $32.4 | $40.1 | +24% |
| 2026 YTD | $40.1 | $45.8 | +14% |
ACT has the edge over BLK on returns for 2026, with the stronger performance.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has finished higher in five of the last six years. It's up 12% so far in 2026.